FindTrial
Sign In

RAY121

DRUG2 trials

Sponsors

Chugai Pharmaceutical

Conditions

Antiphospholipid Syndrome (APS)Behçet's Syndrome (BS)Bullous Pemphigoid (BP)Dermatomyositis (DM)Immune Thrombocytopenia (ITP)Immune-mediated Necrotizing Myopathy (IMNM)

Phase 1

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
RecruitingNCT06371417
Chugai PharmaceuticalAntiphospholipid Syndrome (APS), Behçet's Syndrome (BS), Bullous Pemphigoid (BP) +3
Start: 2024-08-19End: 2027-06-30Target: 144Updated: 2026-07-22
Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)
Enrolling by invitationNCT06723106
Chugai PharmaceuticalAntiphospholipid Syndrome (APS), Behçet's Syndrome (BS), Bullous Pemphigoid (BP) +3
Start: 2024-12-09End: 2028-02-28Target: 144Updated: 2026-07-17